Drug
Voltaren®
Voltaren® is a pharmaceutical drug with 4 clinical trials. Historical success rate of 33.3%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
33.3%
Based on 1 completed trials
Completion Rate
33%(1/3)
Active Trials
0(0%)
Results Posted
200%(2 trials)
Terminated
2(50%)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_3
1
25%
Ph phase_4
1
25%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(1)
Terminated(2)
Other(1)
Detailed Status
Terminated2
unknown1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
33.3%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (25.0%)
Phase 31 (25.0%)
Phase 41 (25.0%)
N/A1 (25.0%)
Trials by Status
unknown125%
terminated250%
completed125%
Recent Activity
0 active trials
Showing 4 of 4
terminatedphase_4
PROUD Study - Preventing Opioid Use Disorders
NCT04766996
terminatedphase_2
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Evaluation of RPH-104 Administered at Different Doses to Patients With Acute Gout Attack
NCT04067492
completedphase_3
Safety and Efficacy of Neuromultivit in Treatment of Vertebrogenic Radiculopathy
NCT02508805
unknownnot_applicable
Electroacupuncture for Sciatica Due to Intervertebral Disc Displacement
NCT02087462
Clinical Trials (4)
Showing 4 of 4 trials
NCT04766996Phase 4
PROUD Study - Preventing Opioid Use Disorders
NCT04067492Phase 2
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Evaluation of RPH-104 Administered at Different Doses to Patients With Acute Gout Attack
NCT02508805Phase 3
Safety and Efficacy of Neuromultivit in Treatment of Vertebrogenic Radiculopathy
NCT02087462Not Applicable
Electroacupuncture for Sciatica Due to Intervertebral Disc Displacement
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4